Moreover, in the context of combined MYCN and PRMD6 overexpression, we did not observe a modulation of tumor onset or progression in comparison to MYCN overexpressing NES cells (Fig. 6D and Figure S2E). This evidence concerns the gene MYCN and neoplasm.